SunWay Biotech , Ltd. Profit Margin

SunWay Biotech , Ltd. (1271.TWO) currently reports a profit margin of 9.16% as of June 2026. That compares with 6.93% in the prior-year period — up 32.3% year over year. That is below the sector sector average of 13.09%. Use the charts on this page to explore SunWay Biotech , Ltd.'s profit margin history and peer comparisons.

SunWay Biotech , Ltd.'s profit margin increased from 6.93% to 9.16% — a 32.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SunWay Biotech , Ltd.'s profit margin of 9.16% is lower than the its sector sector average of 13.09%. That is roughly 30.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but SunWay Biotech , Ltd.'s current 9.16% should be judged against industry norms (sector average: 13.09%) and against 1271.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 9.16%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.09%. From there, open related valuation or income-statement pages for SunWay Biotech , Ltd., and consider following 1271.TWO for alerts when major investors trade the stock.